Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 28, 2024 · 10-K · 88 days after period end · 0000950170-24-038049
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Net Income | -$5.48M | -$11.23M | -$7.15M | -$4.72M |
| EPS Diluted | — | — | -$0.76 | -$1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 28, 2024 · 88 d after period end
